Grove Collaborative Holdings heads into its May 11 earnings call with a mixed Q1 print already on the tape — a beat on the bottom line, a notable miss on the top, and a raised full-year outlook that bulls and bears will parse very differently.
The short positioning tells a cautious story heading into that call. Short interest runs at roughly 4.4% of the free float — modest in absolute terms, but the ORTEX short score of 76.4 places the stock in elevated company. Availability is tight at 45.7%, meaning less than one share remains available to borrow for every two already lent out. Borrow costs, running near 6.4% annualised, have jumped about 25% over the past week. That combination — firm short interest, tightening availability, rising borrow cost — points to a lending market that is becoming incrementally harder for new shorts to access. The stock itself has recovered 12.6% over the past week to close at $1.25, though it remains down just over 5% on the month.
Options positioning is constructive rather than defensive. The put/call ratio is 0.34, slightly above its 20-day average of 0.29 but nowhere near alarming — the z-score is just 0.64. Against a 52-week high PCR of 1.17, that reads as a market leaning toward calls. The earnings history adds some context: the two most recent prints both produced modest negative reactions, with the stock falling roughly 1.6% and 2.3% on the day in the two prior Q1 and Q4 results respectively.
The analyst debate is thin but structurally divided. Canaccord Genuity carried a Buy rating with a $2.00 target as of November 2025 — above the current price — citing Grove's positioning in the eco-friendly consumer products space. Telsey Advisory Group downgraded to Market Perform last May, settling on a $1.20 target that is now below where the stock trades. The bull case rests on brand differentiation in natural cleaning and personal care, where Grove competes against conventional CPG giants. Bears point to commodity cost volatility and a consumer spending backdrop that has weakened appetite for premium-priced discretionary goods. CEO Jeff Yurcisin and Acting CFO Tom Siragusa both sold small amounts of stock in February — amounts too modest to read as a directional signal — while net insider activity over the 90-day window was slightly positive at roughly 64,900 net shares.
The May 11 call is less about whether Q1 was clean and more about whether management can credibly defend the raised revenue guidance against a backdrop where Q1 revenue came in $5 million short of Street expectations.
See the live data behind this article on ORTEX.
Open GROV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
